- A no good, very bad week for the FDA
- Doctors express “grave concerns” at GMC action after GP is suspended over laptop claim
- Waking up to monkeypox
- GPs face huge pension tax bills this year after rise in inflation
- Forte fields demand to liquidate from top shareholder who says latest asset came 'out of thin air'
- Forte fields demand to liquidate from top shareholder who says latest asset came 'out of thin air'
- STAT+: New kind of off-the-shelf cancer vaccine reduces metastasis in animal experiments
- Minute Insight: Angle’s Parsortix Gets FDA Approval, Marking New Era For Liquid Biopsy
- Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
- Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
- EU Tracking CTR Impact On Clinical Trials Environment
- Antimicrobial use data reporting per animal categories (numerator) - Manual for reporting the data to EMA
- What is the role of minimally invasive surgical treatments for benign prostatic enlargement?
- EMA and European Infrastructure for Translational Research (EATRIS) webinar on Scientific Advice for Advanced Therapy Medicinal Products (ATMPs): what and when to ask, Online, 13.00 - 14.00 Amsterdam time (CEST), from 10/06/2022 to 10/06/2022
- Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 16-19 May 2022
Subscribe to Regular Updates
Get insights on clinical trial transparency and regulatory changes.